HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Sans Selected Research

Crohn Disease (Crohn's Disease)

2/2007Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
9/2005Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
4/2003The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease.
9/2000Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Sans Research Topics

Disease

5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2005 - 05/2000
5Colitis
04/2001 - 05/2000
4Crohn Disease (Crohn's Disease)
02/2007 - 09/2000
2Ulcerative Colitis
10/2000 - 09/2000
1Esophageal Neoplasms (Esophageal Cancer)
01/2008
1Stomach Neoplasms (Stomach Cancer)
01/2008
1Infections
01/2008
1Ileal Diseases
02/2007
1Liver Diseases (Liver Disease)
06/2002
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2001
1Chronic Hepatitis C
08/2001
1Fibrosis (Cirrhosis)
08/2001
1Lung Injury
01/2001
1Ischemia
01/2001
1Hemorrhage
10/2000
1Necrosis
07/2000
1Inflammation (Inflammations)
06/2000

Drug/Important Bio-Agent (IBA)

2Plasminogen InactivatorsIBA
02/2007 - 04/2003
2Plasminogen Activator Inhibitor 1IBA
02/2007 - 04/2003
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2001 - 10/2000
2Dextran SulfateIBA
04/2001 - 10/2000
2P-SelectinIBA
04/2001 - 01/2001
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2001 - 10/2000
2Trinitrobenzenesulfonic AcidIBA
04/2001 - 05/2000
2Ethanol (Ethyl Alcohol)IBA
01/2001 - 05/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2001 - 07/2000
2SteroidsIBA
10/2000 - 09/2000
2Heparin (Liquaemin)FDA LinkGeneric
10/2000 - 07/2000
1CytokinesIBA
09/2005
1Pancreatitis-Associated ProteinsIBA
09/2005
1Messenger RNA (mRNA)IBA
09/2005
1CD40 Ligand (CD40L)IBA
07/2004
1AntibodiesIBA
06/2002
1Alanine Transaminase (SGPT)IBA
08/2001
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2001
1OximesIBA
07/2001
1SelectinsIBA
04/2001
1Sulfonic AcidsIBA
04/2001
1AcidsIBA
01/2001
1MethylprednisoloneFDA LinkGeneric
10/2000
1Cell Adhesion MoleculesIBA
10/2000
1Cell Adhesion Molecule-1IBA
10/2000
1Therapeutic UsesIBA
10/2000
1Peroxidase (Myeloperoxidase)IBA
10/2000
1tepoxalinIBA
06/2000
1LeukotrienesIBA
06/2000
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2000
1Glutathione (Reduced Glutathione)IBA
05/2000
1Acetylcysteine (Siran)FDA LinkGeneric
05/2000

Therapy/Procedure

3Therapeutics
04/2003 - 10/2000
1Esophagectomy
01/2008
1Gastrectomy
01/2008